全癌症分析发现CD248是多种瘤类型的潜在目标
Li Guo1, Yan Liao1, Xuyang Zhang1
1Chongqing Key Laboratory of Oral Diseases, Stomatological Hospital of Chongqing Medical University, Chongqing, China.
Frontiers in pharmacology
|April 25, 2025
概括
CD248是癌症早期检测和预后的潜在生物标志物. 高CD248表达与晚期癌症和患者不良结果相关,这表明它是治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 瘤是全球主要的死亡原因,通常是由于晚期诊断.
- 目前的癌症治疗在有效性方面面临挑战,并承担重大财务负担.
- 识别早期预后生物标志物对于改善患者的治疗结果至关重要.
研究的目的:
- 研究CD248在胰癌分析中的作用.
- 评估CD248在各种瘤类型中的诊断和预后潜力.
- 探索CD248对头部和部状细胞癌 (HNSC) 进展的功能影响.
主要方法:
- 使用诸如人类蛋白质图集,GEPIA2,cBioPortal和TIMER等数据库进行生物信息分析.
- 定量实时PCR (qRT-PCR) 和西斑检测CD248mRNA和HNSC细胞系中的蛋白质水平.
- 功能性测试包括穿孔,伤愈合和EDU测试,以评估CD248对HNSC细胞入侵,迁移和增殖的影响.
主要成果:
- 在各种癌症中,CD248表达显著升高,与晚期和不良预后相关.
- CD248中的遗传变化与患者不良结果有关.
- CD248主要表达在树皮纤维细胞上,与免疫细胞透有积极的相关性.
- 抑制CD248抑制了HNSC细胞中的入侵,迁移和增殖.
结论:
- 高CD248表达与泛癌进展,免疫细胞透和患者预后有关.
- CD248显著影响瘤细胞的功能,如入侵,迁移和增殖.
- CD248是一种潜在的新型瘤蛋白,也是各种癌症的有希望的治疗点.
关键词:
CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD248 CD249 CD248 CD248 CD249 CD248 CD248 CD249 CD248 CD248 CD249免疫细胞是免疫细胞.总体存活率 总体存活率胰腺癌是一种癌症.一个单细胞测序.有针对性的治疗.更多相关视频
06:05Author Spotlight: Multiplex Immunofluorescence Combined with Spatial Image Analysis for the Clinical and Biological Assessment of the Tumor Microenvironment
Published on: June 2, 2023
6.9K
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
1.4K
相关概念视频
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...